Reported treatment of hypertension by family physicians in Sweden and Minnesota: a physician survey of practice habits
- 1 September 1995
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 238 (3) , 215-221
Abstract
Objectives. To compare family physicians' reported practice habits on hypertension in Sweden and Minnesota, and to assess to what extent different national guidelines account for differences.Design. Random samples of family physicians were selected for telephone interviews on their practice of hypertension.Setting. Primary care in southern Sweden and in Minnesota.Subjects. Family medicine specialists. Participation rates were 236/264 (89%) in Sweden and 183/209 (88%) in Minnesota.Main outcome measures. Cut‐off levels, and non‐pharmacological and pharmacological treatment of hypertension, related to three case scenarios: a 48‐year‐old man, a 65‐year‐old man and a 65‐year‐old woman.Results. Swedish physicians reported significantly higher levels of diastolic blood pressure than Minnesota physicians for the institution of treatment of hypertension for all case scenarios. In both countries, physicians adhered to the cut‐off levels of their national guidelines in the case of the 48‐year‐old man. Minnesota physicians did not use age as a modifying factor for treatment cut‐off levels, as did Swedish physicians. Swedish physicians emphasized alcohol, fat and stress reduction, and Minnesota physicians weight and salt reduction as non‐pharmacological treatment. While Swedish physicians generally preferred beta‐blockers, Minnesota physicians chose ACE inhibitors or calcium channel blockers as the first choice drug.Conclusion. Swedish and US guidelines on hypertension were identical except for higher cut‐off level for drug treatment in Sweden. Minnesota physicians reported cut‐off levels close to national guidelines. For 65‐year‐old patients, Swedish physicians reported applying a higher cut‐off level than indicated by guidelines. Swedish physicians also reported preferring less expensive drugs. As a consequence of the differing national guidelines and the identified physicians' practice habits in the two medical communities, it is likely that the segments of the populations treated and the drug costs differ substantially.Keywords
This publication has 11 references indexed in Scilit:
- The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of internal medicine (1960), 1993
- Dissemination and Implementation of Guidelines for Lipid LoweringFamily Practice, 1991
- The costs of treating hypertension — an analysis of different cut-off pointsHealth Policy, 1991
- Changes in physician practice for the prevention of cardiovascular diseaseArchives of internal medicine (1960), 1991
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- Do Practice Guidelines Guide Practice?New England Journal of Medicine, 1989
- Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure.American Journal of Public Health, 1988
- The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1988
- 1986 Guidelines for the Treatment of Mild Hypertension: Memorandum from a WHO/ISH MeetingJournal Of Hypertension, 1986
- The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1984